Fig. 6From: Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practiceSensitivity analysis based on GLP-1RA type. Results of Cox regression on primary and secondary outcomes, run separately for the comparison between human-based or exendin-based GLP-1RA versus DPP-4iBack to article page